Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.6/10
Best for: knowing which pharmacy fills the vial: it names Belmar Pharmacy
Breeze Meds' strongest column is the clinical side: which molecules it will prescribe, and how it handles dosing.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
In the price
Clinician visits
Not stated
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Prices checked August 2026
Breeze Meds is a Georgia-based telehealth seller shipping to all 50 states, with compounded semaglutide at $199/mo, tirzepatide at $399/mo, and NAD+ at $169/mo. It is LegitScript certified, names its medical team (Dr. Ana Lisa Carr MD and Dr. Kelly Tenbrink MD), and works through a 4-pharmacy compounding network via Lion MD: Belmar, Strive, Epiq Scripts, and Casa Pharma Rx.
Yes. Breeze Meds is a real, operating US company, and we found no FDA warning letters issued to it. Its site shows LegitScript certification. We rate it 7.6/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Breeze Meds has no code to type in. The current offer: GLP-1 treatment starts at $199/mo with the current promo auto-applied plus free shipping (no code needed). It applies at checkout on its own. Coupon sites advertising a "Breeze Meds promo code" are not a source we can vouch for.
See how Breeze Meds compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Best for: knowing which pharmacy fills the vial: it names VialsRx
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Six columns, each one computed from something Breeze Meds has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
$199/month is 8% above the $185 median for compounded semaglutide across the sellers we compare.
Dispenses semaglutide and tirzepatide, compounded only. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
A price is shown before the questionnaire starts.
It names the pharmacy that fills its prescriptions. It shows a price before asking for health information. It lists the states it serves.
Serves 50 of 50 states.
The price covers the medication and shipping.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
Each one has its own guide: how the molecule works, the dosing schedule, the side effects that show up in practice, and what the trials actually measured.
Breeze Meds sells peptides beyond the GLP-1s. Tap one to read what the evidence says about it.
Prices re-verified
GLP-1 injection starting at $199.
The published price is 'Starting at $399'. Plan prices appear only after the intake questionnaire.
Rendered card 'Oral Semaglutide / Starting at $299 / One dissolvable tablet per day.' Catalog bundles: 899/3mo, 1799/6mo, 3498/yr.
Rendered card 'Oral Tirzepatide / Starting at $399 / One dissolvable tablet per day.' Catalog bundles: 1199/3mo, 2399/6mo, 4799/yr.
Check the price yourself before you pay
Every figure here was read off Breeze Meds's own checkout on the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
Each partner below is a 503A or 503B pharmacy that Breeze Meds routes prescriptions through. Each entry is anchored to a verbatim primary-source quote from the provider’s or pharmacy’s own site.
“Belmar Pharmacy | Phone: 800-525-9473 | belmarpharmasolutions.com / Strive Pharmacy | Phone: 855-405-5993 | strivepharmacy.com / Epiq Scripts | Phone: 833-654-3553 | epiqscripts.com / Casa Pharma Rx | Phone: 877-937-6868 | casapharmarx.com”
“Belmar Pharmacy | Phone: 800-525-9473 | belmarpharmasolutions.com / Strive Pharmacy | Phone: 855-405-5993 | strivepharmacy.com / Epiq Scripts | Phone: 833-654-3553 | epiqscripts.com / Casa Pharma Rx | Phone: 877-937-6868 | casapharmarx.com”
“Belmar Pharmacy | Phone: 800-525-9473 | belmarpharmasolutions.com / Strive Pharmacy | Phone: 855-405-5993 | strivepharmacy.com / Epiq Scripts | Phone: 833-654-3553 | epiqscripts.com / Casa Pharma Rx | Phone: 877-937-6868 | casapharmarx.com”
“Belmar Pharmacy | Phone: 800-525-9473 | belmarpharmasolutions.com / Strive Pharmacy | Phone: 855-405-5993 | strivepharmacy.com / Epiq Scripts | Phone: 833-654-3553 | epiqscripts.com / Casa Pharma Rx | Phone: 877-937-6868 | casapharmarx.com”
Breeze Meds charges $199/month.
For compounded semaglutide, the median across the sellers we compare is $185/month, so Breeze Meds' $199 lands mid-market. Price is unlikely to be the deciding factor.
RNK Health dispenses semaglutide and tirzepatide from $197/month, which makes it the fair comparison to run before you commit here.
Breeze Meds prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two best-evidenced weight-loss molecules currently on the market. These are compounded preparations from a licensed pharmacy rather than approved pens, which is where the lower price comes from. A compounded drug is not FDA-approved as a finished product: the specific preparation has not been reviewed for safety, efficacy or manufacturing quality.
A needle-free oral option is genuinely uncommon and is the reason some readers will look at Breeze Meds at all. Set expectations on the evidence, though: the published weight-loss trials for these molecules used injections. Oral and sublingual delivery of peptides is far less studied, so treat it as a route that solves the needle problem rather than as a proven equal to the shot.
Breeze Meds tells you its price before you start the medical questionnaire, that it treats patients in all 50 states, and the pharmacy that fills its prescriptions. We found no FDA warning letters issued to Breeze Meds. Because the medication is compounded, the named pharmacy is the detail that matters most: its license is the one you can look up. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Breeze Meds lands mid-market on price without a standout advantage or an obvious problem. It comes down to whether its particular package fits you. HumeCare+ is the nearest comparison we review, and worth reading alongside this.
The Bottom Line
Breeze Meds' strongest column is the clinical side: which molecules it will prescribe, and how it handles dosing.
Starting at $199 a month. Check today's price, then start the intake.
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these three counts, another seller does better.
The sellers closest to Breeze Meds on medication and price.
The words sellers use, defined. Tap any term.
Cited across this Breeze Meds review: primary regulatory filings, and peer-reviewed studies.
Plans start at $199 a month. Whether you qualify is a clinician's decision, made after your intake.